MORF - Morphic Holding Inc. Investors Should Contact Robbins LLP for Information About Our Investigation of MORF | Benzinga
SAN DIEGO, Nov. 21, 2023 (GLOBE NEWSWIRE) --
Shareholder rights law firm Robbins LLP is investigating Morphic Holding, Inc. (NASDAQ:MORF) to determine whether certain Morphic officers and directors violated securities laws and breached fiduciary duties to shareholders. Morphic is a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer.
What Now: Morphic Holding, Inc. shareholders have legal options. If you own shares of Morphic Holding, Inc. and have lost ...